Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Reprise Biomedical
AddedFeb 17, 2024
UpdatedJun 18, 2026
Reprise Biomedical

Reprise Biomedical

Series A

Reprise Biomedical: A Minnesota-based startup commercializing biological medical devices with unique technology.

HQ
Plymouth, MN, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Reprise Biomedical, founded in June 2019 as a spin-off from Miromatrix Medical Inc., is a Minnesota-based startup dedicated to commercializing biological medical devices. The company leverages proprietary perfusion decellularization technology to create products that support rapid cellular integration. Their product lineup includes Miro3D, MiroDerm, MiroTract, and MiroFlex, all designed to provide advanced solutions for healing, particularly for deep and tunneling wounds.

Notable figures associated with Reprise Biomedical include key personnel from Miromatrix Medical Inc., who played a significant role in the company's inception. The startup has garnered attention for its innovative approach to medical device manufacturing, achieving significant milestones in product development and market penetration. Reprise Biomedical's impact is evident in its contribution to advancing wound care technology, offering effective and efficient healing solutions that address complex medical needs.

Reprise Biomedical - Similar Companies

Miromatrix Medical logo

Miromatrix Medical

miromatrix.com

Imbed Biosciences logo

Imbed Biosciences

imbedbio.com

BiomedInnovations logo

BiomedInnovations

Circle Biologics logo

Circle Biologics

EmboMedics logo

EmboMedics

Biomimedica logo

Biomimedica

biomimedica.com

Micron Biomedical logo

Micron Biomedical

NeXtGen Biologics logo

NeXtGen Biologics

Protege Biomedical logo

Protege Biomedical

NXT Biomedical logo

NXT Biomedical

nxtbiomedical.com

Minnesota Medical Technologies logo

Minnesota Medical Technologies

mnmedtech.us

Lifecore Biomedical logo

Lifecore Biomedical

lifecore.com

Fast Biomedical logo

Fast Biomedical

EndoCellutions logo

EndoCellutions

endocellutions.com

Lumen Biomedical logo

Lumen Biomedical

lumenbio.com

Reprise Biomedical - Quick Facts

Who are Reprise Biomedical's competitors?

Companies similar to Reprise Biomedical include Miromatrix Medical, Imbed Biosciences, BiomedInnovations and Circle Biologics.

When was Reprise Biomedical founded?

Reprise Biomedical was founded in 2019.

Where is Reprise Biomedical's headquarters located?

Reprise Biomedical's headquarters is located in Plymouth, MN, US.

When was Reprise Biomedical's last funding round?

Reprise Biomedical's most recent funding round was for $8M (USD) in November 2023.

How much has Reprise Biomedical raised to-date?

As of Nov 1, 2023, Reprise Biomedical has raised a total of $40.8M (USD).

How many employees does Reprise Biomedical have?

Reprise Biomedical has 39 employees as of Feb 5, 2024.

Reprise Biomedical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research